SOX9 and colorectal cancer: Although primarily characterized as a repressor of Wnt/β-catenin target genes, correlative evidence hints at a more complex relationship between SOX9 and Wnt/β-catenin signaling in the intestinal epithelium and in colorectal cancer (CRC).